<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Date of Report October 24, 1996
----------------
IVAC MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 34 - 95-3177311
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
10221 WATERIDGE CIRCLE 92121-2733
SAN DIEGO, CALIFORNIA (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (619) 458-7000
<PAGE>
ITEM 5. OTHER EVENTS.
On October 24, 1996, the Company issued a Press Release announcing
expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period
with respect to transactions contemplated in an Agreement and Plan of Merger,
executed on August 23, 1996, among IVAC Holdings, Inc.; the Company; IMED
Corporation ("IMED"), a subsidiary of Advanced Medical, Inc.; a wholly owned
subsidiary of IMED and the holders of Common Stock of Holdings named therein.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements of business acquired.
None.
(b) Pro forma financial information.
None.
(c) Exhibits
99.1 Press release dated October 24, 1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IVAC MEDICAL SYSTEMS, INC.
Date: October 25, 1996 By: /s/ Debra P. Crawford
----------------------
Debra P. Crawford
Chief Financial Officer and
Vice President of Finance
and Administration
<PAGE>
Exhibit 99.1
FOR IMMEDIATE RELEASE
OCTOBER 24, 1996
IVAC MEDICAL SYSTEMS ANNOUNCES
TERMINATION OF HART-SCOTT RODINO ANTITRUST
IMPROVEMENTS ACT WAITING PERIOD
CONTACT: Bill Mercer, IVAC President and CEO (619) 458-7551
Joleen Schultz, (619) 236-1332
SAN DIEGO, CA. October 24, 1996 -- IVAC Medical Systems, Inc., a privately
held company, announced today that it had been notified by the Federal Trade
Commission that termination of the waiting period required under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, had been
granted in connection with its previously announced combination with IMED
Corporation, a subsidiary of Advanced Medical, Inc. (ASE:AMA). The closing of
the combination is subject to certain other closing conditions, including the
completion of the financing necessary to consummate the transaction.
Founded in 1968, IVAC is a leading provider of infusion systems and
related technologies to the healthcare industry. The company's principal line
of business is the design, manufacture and marketing of intravenous infusion
therapy products, vital signs instruments and related disposables. IVAC's
products are distributed in over 120 countries worldwide. IVAC Medical Systems
was purchased from Eli Lilly & Company on December 31, 1994 by DLJ Merchant
Banking Partners, LP, River Medical, Inc. and other entities and investors.
IVAC's worldwide corporate headquarters, R&D facilities, and manufacturing
facilities are located in San Diego, with additional manufacturing facilities in
Creedmoor, N.C.; Hampshire, U.K.; and Tijuana, Mexico.
Website - IVAC www.ivac.com/~ivac
